MAM
Rolls-Royce names Sashi Mukundan EVP to steer India transformation
MUMBAI: Rolls-Royce is shifting gears in India with a new leadership appointment. The engineering giant has announced Sashi Mukundan as its executive vice president, transformation India, effective October 2025, marking a significant step in strengthening its presence and partnerships across the country.
In his new role, Mukundan will lead government and business relations for Rolls-Royce in India and play a key part in accelerating the Group’s growth in one of its most strategic global markets.
For nearly a century, Rolls-Royce has been woven into India’s industrial fabric, combining its heritage of British engineering excellence with local innovation, manufacturing, and collaboration. From powering India’s skies and seas including the Air Force, Navy, Coast Guard, and major airlines to supporting critical infrastructure like railways, airports, hospitals, and data centres, the company’s footprint in India continues to expand.
Commenting on the appointment, Rolls-Royce CEO Tufan Erginbilgic said, “Sashi has a track record of delivering significant commercial growth that has contributed to India’s impressive economic success story. His appointment reaffirms our commitment to expanding our footprint and deepening our partnerships in India. We aspire to become a strategic partner by co-creating, co-developing, and co-manufacturing power and propulsion technologies in India, for India, and for the world, making a meaningful contribution to Viksit Bharat 2047.”
Mukundan’s appointment comes as Rolls-Royce continues its multi-year transformation into a high-performing, resilient, and globally competitive business. The move signals the company’s intent to align closely with India’s vision of self-reliance and innovation leadership, powered by collaboration, technology, and trust.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
